SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling

SU5416 plus chronic hypoxia causes pulmonary arterial hypertension in rats and is assumed to occur through VEGFR2 inhibition. Cabozantinib is a far more potent VEGFR2 inhibitor than SU5416. Therefore, we hypothesized that cabozantinib plus hypoxia would induce severe pulmonary arterial hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitapara, Ravikumar, Sugarragchaa, Chuluunbaatar, Zisman, Lawrence S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202272/
https://www.ncbi.nlm.nih.gov/pubmed/34178306
http://dx.doi.org/10.1177/20458940211021528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202272/
https://www.ncbi.nlm.nih.gov/pubmed/34178306
http://dx.doi.org/10.1177/20458940211021528

Ejemplares similares